Darwin Global Management, Ltd.
- SEC CIK
- 0001839209
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 4
- +2 vs. Q3 2022
- Portfolio value
- $160.6M
- +$94.2M (+141.9%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 297,701 | $112.8M | 70.2% | +297,701 | New | History |
| KROSKeros Therapeutics, Inc. | COM | 428,532 | $20.6M | 12.8% | +428,532 | New | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 7,584,489 | $17.2M | 10.7% | +7,584,489 | New | History |
| RXDXPrometheus Biosciences, Inc. | COM | 91,379 | $10.1M | 6.3% | +91,379 | New | History |
Sold out since Q3 2022 (2)
Positions held at the end of Q3 2022 that are gone from this filing.